An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found ...

Rutgers received a $3.2 million dollar grant from the National Institutes of Health to study the impact of micronanoplastics ...

Former independent presidential candidate and antivaccine advocate Robert F. Kennedy Jr. said that former President Trump ...

With COVID-19 still spreading and mpox emerging as a public health emergency of international concern, the National ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug used to treat bone marrow cancer and Kaposi sarcoma is ...

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...

Bioengineer Ankur Singh works to create functional models of the human immune system in the lab. (Credit: Ankur Singh) ...

Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

Large NIH-funded study supports previous studies showing potential benefit.